BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 10938130)

  • 1. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
    Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
    Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
    Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
    Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
    Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
    Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
    Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R
    J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the BTB domain from PLZF.
    Ahmad KF; Engel CK; Privé GG
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12123-8. PubMed ID: 9770450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of FAZF as a novel BMP2-induced transcription factor during osteoblastic differentiation.
    Ikeda R; Yoshida K; Inoue I
    J Cell Biochem; 2007 May; 101(1):147-54. PubMed ID: 17171645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
    Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
    Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
    Deltour S; Guerardel C; Leprince D
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
    Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
    Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms. Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia.
    Mitchelmore C; Kjaerulff KM; Pedersen HC; Nielsen JV; Rasmussen TE; Fisker MF; Finsen B; Pedersen KM; Jensen NA
    J Biol Chem; 2002 Mar; 277(9):7598-609. PubMed ID: 11744704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
    Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The zinc finger domain of Tzfp binds to the tbs motif located at the upstream flanking region of the Aie1 (aurora-C) kinase gene.
    Tang CJ; Chuang CK; Hu HM; Tang TK
    J Biol Chem; 2001 Jun; 276(22):19631-9. PubMed ID: 11279021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI; Chang WJ; Cho SG; Kim IY
    J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
    Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
    Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
    Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
    Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A; Buchholz DR; Obata K; Shi YB
    J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
    Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.